TY - JOUR
T1 - Complications of lasers and light treatments
AU - Alam, Murad
AU - Warycha, Melanie
N1 - Copyright:
Copyright 2012 Elsevier B.V., All rights reserved.
PY - 2011/11
Y1 - 2011/11
N2 - Cutaneous lasers and lights, and also more novel cutaneous energy modalities like radiofrequency and ultrasound, are in general very safe interventions with an associated rapid healing time. Posttreatment sequelae are usually mild and spontaneously resolving, with erythema and edema lasting hours to days. More troublesome, less common short-term adverse events include urticaria, erosions, crusting, ecchymoses, blistering, and infection. Medium-term adverse events include hyperpigmentation, hypopigmentation, a line of demarcation, burns, textural imperfections, and delayed reepithelialization. Long-term to permanent adverse events, which are fortunately rare, include indentation, scar, and ocular damage. With few exceptions, there are management strategies for avoiding laser adverse events, and, if they do occur, for mitigating their impact.
AB - Cutaneous lasers and lights, and also more novel cutaneous energy modalities like radiofrequency and ultrasound, are in general very safe interventions with an associated rapid healing time. Posttreatment sequelae are usually mild and spontaneously resolving, with erythema and edema lasting hours to days. More troublesome, less common short-term adverse events include urticaria, erosions, crusting, ecchymoses, blistering, and infection. Medium-term adverse events include hyperpigmentation, hypopigmentation, a line of demarcation, burns, textural imperfections, and delayed reepithelialization. Long-term to permanent adverse events, which are fortunately rare, include indentation, scar, and ocular damage. With few exceptions, there are management strategies for avoiding laser adverse events, and, if they do occur, for mitigating their impact.
KW - edema
KW - erythema
KW - hyperpigmentation
KW - hypopigmentation
KW - scar
UR - http://www.scopus.com/inward/record.url?scp=84860129534&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84860129534&partnerID=8YFLogxK
U2 - 10.1111/j.1529-8019.2012.01476.x
DO - 10.1111/j.1529-8019.2012.01476.x
M3 - Article
C2 - 22515672
AN - SCOPUS:84860129534
SN - 1396-0296
VL - 24
SP - 571
EP - 580
JO - Dermatologic Therapy
JF - Dermatologic Therapy
IS - 6
ER -